Drawing for BIOLOGICS BY MCKESSON

USPTO serial 88227003

BIOLOGICS BY MCKESSON

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JOHN, CRISTEL M
Law office
TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 600: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BIOLOGICS BY MCKESSON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Auma N. Reggy

Auma N. Reggy MCKESSON CORPORATION2 NATIONAL DATA PLAZA NEATLANTA, GA 30329UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035A pharmaceutical dispensing channel for specialty medication / therapies, namely, an independent specialty pharmacy dispensing oncology and other complex therapeutic area medicationsACTIVEOct 1, 2018
042Providing assistance in terms of medication dispensing, administration, and patient management, namely, supporting patients in gaining access to complex and high-cost specialty medications; providing services that help clinicians, biopharma, life science companies, researchers and payors monitor and achieve positive outcomes for patientsACTIVEOct 1, 2018
044Pharmaceutical advice related to the delivery of oncology drugs; pharmacist services needed to fill prescriptions; medical counseling, namely, counseling for patients with cancer and other complex conditions to ensure safety and compliance in taking oncology and other highly complex specialty drugsACTIVEOct 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2020MAB0ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE—
Jun 16, 2020ABN0ABANDONMENT - INCOMPLETE RESPONSE—
May 21, 2020RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
May 21, 2020RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
May 21, 2020RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Apr 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 30, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 30, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 30, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 30, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2019ALIEASSIGNED TO LIE—
Sep 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2019DOCKASSIGNED TO EXAMINER—
Jan 5, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance